Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
Abstract Background Biliary tract cancer (BTC) is a relatively rare but aggressive gastrointestinal cancer with a high mortality rate. Cancer stem cell (CSC) populations play crucial roles in tumor biology and are responsible for the low response to anti-cancer treatment and the high recurrence rate...
Main Authors: | , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
BMC
2024-03-01
|
丛编: | BMC Cancer |
主题: | |
在线阅读: | https://doi.org/10.1186/s12885-024-12082-3 |